Titration and mapping of the active site of cysteine proteinases from Porphyromonas gingivalis (Gingipains) using peptidyl chloromethanes

被引:153
作者
Potempa, J
Pike, R
Travis, J
机构
[1] UNIV CAMBRIDGE, CTR MRC, DEPT HAEMATOL, CAMBRIDGE CB2 2QH, ENGLAND
[2] UNIV GEORGIA, DEPT BIOCHEM & MOL BIOL, ATHENS, GA 30205 USA
关键词
affinity labeling; enzyme inhibition; pathogenicity; periodontitis; proteolytic enzyme; virulence factors;
D O I
10.1515/bchm.1997.378.3-4.223
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Porphyromonas gingivalis is one of the major pathogens associated with periodontal disease and releases powerful cysteine proteinases known as the gingipains, which are key virulence factors for this organism. The three forms of gingipains, gingipain R1, gingipain R2 (gingipain Rs) and gingipain K, which cleave specifically after arginine (R) or lysine (K) residues, were characterized in terms of the kinetics of their interaction with a wide range of synthetic peptidyl chloromethane inhibitors and a peptidyl (acyloxy)-methane. Chloromethane inhibitors were found to inhibit all the enzymes to varying degree dependent on the peptidyl components of the inhibitor. Thus, inhibitors containing a basic residue at P1 rapidly inactivated the gingipains and some specificity could be seen at the P2 site. The (acyloxy)methane inhibitor, Cbz-Phe-Lys-CH2OCO-2,4,6-Me-3-Ph, was very specific in its rapid inhibition of gingipain K over the gingipains R. This inhibitor, together with the peptidyl chloromethanes, D-Phe-Pro-Arg-CHpCI and D-Phe-Phe-Arg-CH2Cl, which reacted most rapidly with the Arg-specific proteinases, could be used to active site titrate purified forms of the enzymes and enzymes found in crude fractions such as intact P. gingivalis cells, vesicles or membrane fractions. From these titrations it was evident that gingipains R were always in an excess of about 3-fold over gingipain K and that the gingipains as a whole made up 85% of the proteolytic activity associated with the bacterium. The elucidation of the kinetics of inhibition by the range of compounds and the development of the titration method for gingipains will considerably aid in future studies on the proteases elaborated by P. gingivalis.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 51 条
  • [1] CHARACTERIZATION, GENETIC-ANALYSIS, AND EXPRESSION OF A PROTEASE ANTIGEN (PRPRI) OF PORPHYROMONAS-GINGIVALIS W50
    ADUSEOPOKU, J
    MUIR, J
    SLANEY, JM
    RANGARAJAN, M
    CURTIS, MA
    [J]. INFECTION AND IMMUNITY, 1995, 63 (12) : 4744 - 4754
  • [2] Analysis of the prtP gene encoding porphypain, a cysteine proteinase of Porphyromonas gingivalis
    BarkocyGallagher, GA
    Han, NM
    Patti, JM
    Whitlock, J
    ProgulskeFox, A
    Lantz, MS
    [J]. JOURNAL OF BACTERIOLOGY, 1996, 178 (10) : 2734 - 2741
  • [3] BIETH JG, 1980, CLIN RES PROC, V16, P183
  • [4] CLONING, EXPRESSION, AND SEQUENCING OF A PROTEASE GENE (TPR) FROM PORPHYROMONAS-GINGIVALIS W83 IN ESCHERICHIA-COLI
    BOURGEAU, G
    LAPOINTE, H
    PELOQUIN, P
    MAYRAND, D
    [J]. INFECTION AND IMMUNITY, 1992, 60 (08) : 3186 - 3192
  • [5] REACTIONS OF PAPAIN AND OF LOW-MOLECULAR-WEIGHT THIOLS WITH SOME AROMATIC DISULFIDES - 2,2'-DIPYRIDYL DISULFIDE AS A CONVENIENT ACTIVE-SITE TITRANT FOR PAPAIN EVEN IN PRESENCE OF OTHER THIOLS
    BROCKLEHURST, K
    LITTLE, G
    [J]. BIOCHEMICAL JOURNAL, 1973, 133 (01) : 67 - 80
  • [6] CHEN ZX, 1992, J BIOL CHEM, V267, P18896
  • [7] CHARACTERIZATION OF THE TRYPSIN-LIKE ENZYMES OF PORPHYROMONAS-GINGIVALIS W83 USING A RADIOLABELED ACTIVE-SITE-DIRECTED INHIBITOR
    CURTIS, MA
    RAMAKRISHNAN, M
    SLANEY, JM
    [J]. JOURNAL OF GENERAL MICROBIOLOGY, 1993, 139 : 949 - 955
  • [8] Cutler Christopher W., 1995, Trends in Microbiology, V3, P45, DOI 10.1016/S0966-842X(00)88874-5
  • [9] CUTLER CW, 1993, J IMMUNOL, V151, P7016
  • [10] Cleavage of human complement component C5 by cysteine proteinases from Porphyromonas (Bacteroides) gingivalis. Prior oxidation of C5 augments proteinase digestion of C5
    Discipio, RG
    Daffern, PJ
    Kawahara, M
    Pike, R
    Travis, J
    Hugli, TE
    [J]. IMMUNOLOGY, 1996, 87 (04) : 660 - 667